Genotropin / Somatrem

Modified on 2009/10/14 21:44 by admin
Genotropin, also known as somatrem, is indicated for the long-term treatment of pediatric patients who have growth failure due to a lack of growth hormone secretions. Genotropin mimics the growth hormone normally produced by the body's pituitary gland. Available by prescription only, Genotropin is administered by injection. The U.S. Food and Drug Administration (FDA) approved the medication in 1985. Genotropin is made by Pharmacia.

Side effects of Genotropin use include, but may not be limited to, ear problems, headache, nausea, vomiting, hip or knee pain, skin rash and carpal tunnel syndrome (rare).

In July 2003, Pharmacia and the FDA revised the CONTRAINDICATIONS and WARNINGS sections of the prescribing information for Genotropin. Fatalities have been reported with the use of growth hormone in pediatric patients with Prader-Willi syndrome and one or more of the following risk factors: severe obesity, history of respiratory impairment or sleep apnea, or unidentified respiratory infection. Male patients with these factors may be at increased risk. See your doctor if you have been injured by Genotropin. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Growth Hormone Drugs: Overview
  2. Headaches
  3. Nausea: Overview
  4. Skin Disorders: Overview
  Name Size